Cognitron

Cognitron

by Christopher Thompson

1 ratings
Free

Rating summary

Details

  • Released
  • Updated
  • March 7, 2025
  • May 20, 2025
Cognitron screenshot #1 for iPhone
Cognitron screenshot #2 for iPhone
Cognitron screenshot #3 for iPhone
🖼️Get Icon
Icons↘︎

About

An AI-powered chat interface designed to assist medical professionals. It can generate health brochures, launch digital surveys, and streamline patient intake to gather useful information before appointments.

AI chat interface
Task execution for doctors
Printable health brochures
Digital survey launching
Patient intake guidance
Show original description

What's New in Cognitron

2.4

May 20, 2025

- Minor improvements and bug fixes.

FAQ

What is Cognitron used for?

Cognitron is an AI chat interface that helps doctors by executing tasks like printing health brochures, launching digital surveys, and guiding patient intake to collect information before appointments.

Is Cognitron free to use?

Yes, Cognitron is available for free. There are no costs associated with downloading or using the application.

What age rating is Cognitron?

Cognitron has an age rating of 17+. This is common for medical applications that may contain complex health information.

How often is Cognitron updated?

The latest version of Cognitron is 2.4, and it was last updated on May 20, 2025. This indicates a recent update, suggesting ongoing development and support.

What devices can I use Cognitron on?

While specific device compatibility is not detailed, Cognitron is a mobile application and is likely available on standard smartphone and tablet operating systems.

What is the user sentiment for Cognitron?

Based on the available rating, Cognitron has received a perfect 5.0 stars from 1 rating, indicating a highly positive initial user experience.

Does Cognitron have ads?

The provided data does not specify whether Cognitron contains advertisements. Further information would be needed to confirm its ad status.

Who developed Cognitron?

Cognitron was developed by Christopher Thompson.